相似文献
1
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine.
Heart. 1997 Mar;77(3):268-72. doi: 10.1136/hrt.77.3.268.
2
Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
Circulation. 2006 Mar 7;113(9):1164-70. doi: 10.1161/CIRCULATIONAHA.105.535161. Epub 2006 Feb 27.
3
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine.
Heart. 1998 Jan;79(1):105. doi: 10.1136/hrt.79.1.105.
4
Age-dependent effect of β-blockers in preventing vasovagal syncope.
Circ Arrhythm Electrophysiol. 2012 Oct;5(5):920-6. doi: 10.1161/CIRCEP.112.974386. Epub 2012 Sep 12.
5
Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
Indian Heart J. 2003 Jan-Feb;55(1):40-3.
6
[Hemodynamic changes during head-up tilt test and predictive value thereof in predicting the efficacy of metoprolol therapy in children with vasovagal syncope].
Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1260-2.
7
Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.
Europace. 2003 Jan;5(1):71-5. doi: 10.1053/eupc.2002.0284.
8
Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.
Pacing Clin Electrophysiol. 1999 Feb;22(2):276-81. doi: 10.1111/j.1540-8159.1999.tb00439.x.
9
Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents.
Med Sci Monit. 2008 Apr;14(4):CR199-203.
10
Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.
Circulation. 1999 Mar 23;99(11):1452-7. doi: 10.1161/01.cir.99.11.1452.
引用本文的文献
1
Cardiac parasympathetic denervation reduces hypoxic tachycardia, baroreflex sensitivity and heart rate variability in humans.
Sci Rep. 2025 Feb 24;15(1):6633. doi: 10.1038/s41598-025-91214-6.
2
Tamsulosin-induced life-threatening hypotension in a patient with spinal cord injury: A case report.
World J Clin Cases. 2022 Sep 6;10(25):9142-9147. doi: 10.12998/wjcc.v10.i25.9142.
3
Twenty-four-hour urine NE level as a predictor of the therapeutic response to metoprolol in children with recurrent vasovagal syncope.
Ir J Med Sci. 2019 Nov;188(4):1279-1287. doi: 10.1007/s11845-019-01979-9. Epub 2019 Feb 13.
4
Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope - a meta-analysis.
Clin Pharmacol. 2010;2:163-7. doi: 10.2147/CPAA.S12873. Epub 2010 Sep 15.
5
Drugs and pacemakers for vasovagal, carotid sinus and situational syncope.
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD004194. doi: 10.1002/14651858.CD004194.pub3.
6
[Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].
Z Kardiol. 2005 Sep;94(9):592-612. doi: 10.1007/s00392-005-0230-5.
7
Current Management of Syncope: Treatment Alternatives.
Curr Treat Options Cardiovasc Med. 2004 Oct;6(5):371-383. doi: 10.1007/s11936-004-0021-8.
8
New approaches to the treatment and prevention of neurally mediated reflex (neurocardiogenic) syncope.
Curr Cardiol Rep. 2004 Sep;6(5):385-90. doi: 10.1007/s11886-004-0042-7.
9
Strategy for the management of vasovagal syncope.
Drugs Aging. 2002;19(3):179-202. doi: 10.2165/00002512-200219030-00003.
10
Neurocardiogenic syncope: aetiology and management.
Drugs. 2001;61(10):1415-23. doi: 10.2165/00003495-200161100-00005.
本文引用的文献
1
Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope.
Circulation. 1996 Mar 1;93(5):973-81. doi: 10.1161/01.cir.93.5.973.
2
Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
N Engl J Med. 1993 Apr 15;328(15):1085-90. doi: 10.1056/NEJM199304153281504.
3
Permanent pacing for cardioinhibitory malignant vasovagal syndrome.
Br Heart J. 1994 Mar;71(3):274-81. doi: 10.1136/hrt.71.3.274.
4
In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
J Pharmacol Exp Ther. 1993 May;265(2):707-12.
5
Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope.
Circulation. 1995 Jul 1;92(1):54-8. doi: 10.1161/01.cir.92.1.54.
6
Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results.
Am Heart J. 1995 Dec;130(6):1250-3. doi: 10.1016/0002-8703(95)90150-7.
7
Clonidine raises blood pressure in severe idiopathic orthostatic hypotension.
Am J Med. 1983 Feb;74(2):193-200. doi: 10.1016/0002-9343(83)90607-1.
8
The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin.
Pacing Clin Electrophysiol. 1988 Aug;11(8):1202-14. doi: 10.1111/j.1540-8159.1988.tb03973.x.
9
Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia.
Am J Cardiol. 1990 Jun 1;65(20):1339-44. doi: 10.1016/0002-9149(90)91324-y.
10
Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing.
Ann Intern Med. 1991 Jun 15;114(12):1013-9. doi: 10.7326/0003-4819-114-12-1013.
Zotero 插件